relative to notice requirements and enforcement for pharmacies dispensing medications intended to induce chemical abortions.
HB 1702 requires pharmacies and medical facilities in New Hampshire to post a standardized notice about mifepristone (a drug used for chemical abortions) when dispensing it. The notice, displayed prominently in specific areas like waiting rooms or pharmacy counters, states that mifepristone may sometimes be reversible if the second pill hasn’t been taken, and provides a contact for resources. Noncompliance could result in a class B felony charge for providers or civil lawsuits seeking damages for patients harmed by the lack of notice. The bill directly affects pharmacies and clinics dispensing mifepristone, with no estimated state or local costs.
Bill status
died
1 of 4 stages cleared
Introduction
Dec 2025
Committee Review
Floor Vote
Governor
Introduced Dec 12, 2025
Last action Feb 27, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
4
Key actions
0
Committee
1
Feb 27, 2026
Committee
Committee Report: Inexpedient to Legislate 02/13/2026 (Vote 17-0; RC) HC 10 P. 102
lower
Dec 12, 2025
Introduced
Introduced 01/07/2026 and referred to Judiciary HJ 1 P. 32
lower
0 primary · 9 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 1702
Scope: NH
Hi! I can help you understand HB 1702. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline